Business
Solos Endoscopy Posts Shareholder Update on OTC Markets.com
Solos Endoscopy Posts Shareholder Update on OTC Markets.com.
About this update from Cyduct Diagnostics Inc.
[{"type":"text","content":"\n \n \n Solos Endoscopy Posts Shareholder Update on OTC Markets.com\n \n \nSolos Endoscopy Posts Shareholder Update on OTC Markets.com\n \n BOSTON, MA--(Marketwired - Jan 10, 2014) - Solos Endoscopy, Inc. (OTC Pink: SNDY) a provider of quality innovative healthcare instruments to Hospitals across the Country, posted an update for the shareholders on OTC Markets.com.\n The Company posted a letter from the President on the OTC Markets website (http://www.otcmarkets.com/financialReportViewer?symbol=SNDY&id=115342) \n Solos Endoscopy completed the Audit with TUV SUD America this past year, which included a comprehensive review of the Solos Endoscopy's Quality Manual and 28 Quality System Procedures for compliance with the international quality system standard ISO 13485:2003, to the European Union's Medical Device Directive (MDD 93/42/EEC) and to the Canadian Medical Device Regulations (SOR/98-282). Since the completion of the Audit, the Company has been in contact with the representatives from both TUV SUD and Expert Resources and expects to be certified to ISO 13485:2003 in the next few weeks. Certification to ISO 13485:2003 will in turn allow Solos Endoscopy to obtain the CE Mark on the majority of endoscopic instruments including the MammoView® devices. \n Solos has several exciting new advances in product development that will change the way minimally invasive procedures are utilized in the medical field in order to treat and prevent disease. These products will allow the physician to examine organs and tissues within the body without the need for intrusive surgery. The Company is currently marketing its next generation breast endoscopy system, the MammoView® system, for early breast cancer detection.\n About Solos Endoscopy, Inc.:\n Solos Endoscopy celebrated its 25th Year of providing quality innovative healthcare instruments to Hospitals across the Country. For more than 25 Years, from medical schools to hospitals, surgeons have trusted Solos Endoscopy to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of disease and medical conditions. Additional information on its FDA approved products is available on the Company's website at: www.solosendoscopy.com.\n Certain statements in this news release may contain...